logo

For the Inventor, By the Inventor

Bucheon, South Korea

Min Jung Kang

This inventor holds 12 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Industry-University Cooperation Foundation Hanyang University, Samsung Electronics Co., Ltd., Inje University Industry-Academic Cooperation Foundation. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Jung Kang. Retrieved from https://idiyas.com/inventor/min-jung-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0


Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 175(Granted Patents)


Location History:

  • Seoul, KR (2008)
  • Daejeon, KR (2016)
  • Bucheon-Si, KR (2007 - 2024)

Company Filing History:

goldMedal6 out of 1,248 
 
Industry-University Cooperation Foundation Hanyang University
 patents
silverMedal5 out of 132,108 
 
Samsung Electronics Co., Ltd.
 patents
bronzeMedal2 out of 69 
 
Inje University Industry-Academic Cooperation Foundation
 patents
4. 1 out of 310 
 
Korea Research Institute of Standards and Science
 patents
where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12186408 - Fusion polypeptides for inhibiting angiogenesis, fusion protein nanocages having multivalent peptides for inhibiting angiogenesis, and theranostic use thereof (2025-01-07),
2. 11866470 - Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses (2024-01-09),
3. 11827679 - Self-assembled nanostructures of elastin- and resilin-based block copolypeptides with stimuli responsiveness and resilience for drug delivery system, tissue engineering and regenerative medicine and methods of preparing the same (2023-11-28),
4. 11518798 - Vascular endothelial growth factor receptor targeting peptide-elastin fusion polypeptides (2022-12-06),
5. 11059870 - Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses (2021-07-13),
6. 10662236 - Vascular endothelial growth factor receptor targeting peptide-elastin fusion polypeptides (2020-05-26),
7. 9297038 - Method and kit for the quantification of nucleic acids (2016-03-29),
8. D571062 - Dishwasher (2008-06-10),
9. D568343 - Refrigerator (2008-05-06),
10. D564282 - Gas oven range (2008-03-18),
11. D561529 - Panel for oven (2008-02-12),
12. D553229 - Dehumidifier (2007-10-16),

Title: The Innovative Mind of Min Jung Kang

Introduction: Min Jung Kang, a talented male inventor hailing from Bucheon-si, South Korea, is a visionary in the field of technological advancements and innovations.

Latest Patents: Kang's latest patents showcase his expertise in cutting-edge technologies, including advancements in artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Min Jung Kang has made significant contributions to various industries, revolutionizing the way we interact with technology on a daily basis. His innovative solutions have garnered international recognition and praise.

Collaborations: Kang has collaborated with leading research institutions, universities, and tech companies to further his inventions and bring them to market. His collaborative spirit has led to groundbreaking developments in the field of innovation.

Conclusion: Min Jung Kang's passion for pushing the boundaries of what is possible through innovation and invention continues to inspire the next generation of inventors. His dedication to creating a better future through technology cements his legacy as a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…